Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Results
Phase 3
This trial compared 2 drugs called imatinib and dasatinib for chronic myeloid leukaemia. The trial was for people whose chronic myeloid leukaemia was recently diagnosed in chronic phase.
Recruitment start: 7 August 2008
Recruitment end: 8 March 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen O'Brien
Bristol-Myers Squibb
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
The Newcastle upon Tyne Hospitals NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/09/003.
Last reviewed: 19 October 2015
CRUK internal database number: 3351
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
